- Correction
- Open Access
- Published:
Correction to: Metalloproteases meprin-ɑ (MEP1A) is a prognostic biomarker and promotes proliferation and invasion of colorectal cancer
BMC Cancer volume 18, Article number: 70 (2018)
- The original article was published in BMC Cancer 2016 16:383
MEP1A knock-down inhibits colorectal cancer cell migration and invasion. Scratch assays and matrigel invasion assays showed that MEP1A knock-down LoVo cells had less migration ability (a) and invasion ability (b) than control LoVo cells. The wound areas were measured 36 h post injury. The results represent mean ± SD of at least 12 wounds and were analyzed by the Student’s t-test (* p < 0.05)
Reference
- 1.
Xiao W, Jian C, Jingtao W, Fudong Y, Senlin Z, Yu Z, Huamei T, Zhihai P. Metalloproteases meprin-ɑ(MEP1A) is a prognostic biomarker and promotes proliferation and invasion of colorectal cancer. BMC Cancer. 2016;16:383. https://doi.org/10.1186/s12885-016-2460-5.
Author information
Additional information
The original article can be found online at https://doi.org/10.1186/s12885-016-2460-5.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Wang, X., Chen, J., Wang, J. et al. Correction to: Metalloproteases meprin-ɑ (MEP1A) is a prognostic biomarker and promotes proliferation and invasion of colorectal cancer. BMC Cancer 18, 70 (2018). https://doi.org/10.1186/s12885-017-3767-6
Received:
Accepted:
Published:
